Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

ON DEMAND - Getting Real About Data Sharing for Drug Development and Drug Safety: What COVID-19 is Teaching us About the Possibilities and How to Move From Anomaly to Precedent

Session Chair(s)

Carla  Rodriguez-Watson, PhD, MPH

Carla Rodriguez-Watson, PhD, MPH

Reagan-Udall Foundation for the FDA, United States

A panel of distinguished leaders in healthcare, consumer advocacy, and regulated industry will discuss how COVID-19 has broken the paradigm for data sharing as it pertains to drug development and drug safety research – and take the audience through an exercise to define shared value to move forward with a renewed commitment to more open data sharing with public health at its core.

Learning Objective : Recognize barriers to data sharing for the purposes of drug safety and pharmacovigilance; Identify shared goals across consumer, health system, government, and industry stakeholders; Outline a platform for the responsible and collaborative engagement in data sharing and linkage for the purpose of drug safety and pharmacovigilance.

Speaker(s)

Sarah  Greene, MPH

Panelist

Sarah Greene, MPH

Independent Consultant, United States

Strategic Consultant and Advisor

Carlos  Garner, PhD

Panelist

Carlos Garner, PhD

Eli Lilly and Company, United States

Vice-President Global Regulatory Affairs

Deven  McGraw, JD, LLM, MPH

Panelist

Deven McGraw, JD, LLM, MPH

Invitae, United States

Lead, Data Stewardship and Data Sharing

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.